A Northwestern Medicine-led study published in the Journal of Clinical Investigation has uncovered why older individuals with ...

A hidden clue may explain why some mutated cells become cancerous and others don’t: how fast they divide. A new study from researchers at Sinai Health in Toronto reveals that the total time it takes ...

A nationwide team led by researchers at Baylor College of Medicine, Texas Children’s Hospital and UPMC Children's Hospital of Pittsburgh has proposed a major revision to how Langerhans cell ...

Subcutaneous administration takes less time and is tied to fewer administration-related reactions than intravenous.

Cardiff Oncology's Onvansertib shows promise in treating RAS-mutated cancers, especially mCRC, with a strong therapeutic profile and potential for high returns if approved. Onvansertib's Phase II ...

CINCINNATI (WKRC) - A new study found that donating blood regularly could improve blood health by increasing the production of blood cells and decrease the chance of blood cancer. The new study, ...

The University of Cincinnati Cancer Center’s Tom Cunningham has received a two-year, $150,000 grant from the Lung Cancer Research Foundation (LCRF) to test approaches to neutralize an enzyme complex ...

Researchers discovered that chronic inflammation fundamentally remodels the bone marrow, allowing mutated stem cell clones to quietly gain dominance with age. Reprogrammed stromal cells and interferon ...

A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and ...